Department of Medicine
-
October 28, 2011
Vanderbilt doctors to screen patients taking statins for genetic risk factors
Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death. -
October 21, 2011
Growth factor boosts beta cells
A growth factor may help grow transplantation-quality pancreas cells for treating diabetes. -
October 18, 2011
Predicting hospital readmission is risky business: study
Each year millions of Americans return to the hospital within 30 days of their previous discharge. Although many readmissions could be preventable, most statistical models for predicting them "perform poorly," according to researchers at Vanderbilt and the Oregon Health and Science University and their affiliated VA medical centers. -
October 13, 2011
Supplements don’t help lung injury patients
Supplements did not improve outcomes of patients with acute lung injury. -
October 7, 2011
Heart protein may be target for colon cancer therapies
A protein critical in heart development may also play a part in colon cancer progression. -
September 28, 2011
New group of faculty endowed chairs celebrated
Ten of Vanderbilt’s new endowed chairs were praised as leaders in their fields and on campus during a Sept. 26 ceremony at the Student Life Center. -
July 20, 2011
Vanderbilt study links military service in Middle East with serious lung disorder
A Vanderbilt study of U.S. soldiers returning from the wars in Iraq and Afghanistan shows a serious lung condition linked to prolonged exposures to sulfur fires and burn pits.